FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amerisource Health Services Verapamil Hydrochloride Extended-Release Recall

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) pe…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Apr 26, 2023
Recall ID
D-0536-2023
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled Verapamil Hydrochloride Extended-Release starting Mar 16, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0536-2023 on Apr 26, 2023. Reason: Failed Dissolution Specifications: Out of specification dissolution results above specified values. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of specification dissolution results above specified values.

Product description

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

Lot numbers, UPCs & expiration codes

Lots: 1008622, 1010026, Exp 2/29/24

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0536-2023
Classification
Class II
Status
Terminated
Recall initiated
Mar 16, 2023
FDA report date
Apr 26, 2023
Quantity
695 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0536-2023, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
91956
Address
2550 John Glenn Ave Ste A
Code information
Lots: 1008622, 1010026, Exp 2/29/24
Postal code
43217-1188
Report date
Apr 26, 2023
Product type
Drugs
Recall number
D-0536-2023
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
695 cartons
Termination date
May 12, 2024
Reason for recall
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 16, 2023
Initial firm notification
Telephone
Center classification date
Apr 14, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0536-2023, published Apr 26, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls